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Non-typhoidal salmonellae (NTS) are increasingly 
recognised as important pathogens causing 
bacteraemia, especially in immunocompromised 
patients.[1] However, there are limited data explicitly 
describing the clinical characteristics and outcome 
in this cohort of individuals.[2] Since the 1980s, recurrent invasive 
salmonellosis has been recognised as an AIDS-defining condition in 
HIV-positive patients.[3] Salmonella meningitis, a rare complication 
of Salmonella sepsis accounting for 0.8 - 6% of all cases of bacterial 
meningitis,[4] was first reported by Ghon in 1907 (cited by Ohaiseadha 
et al.[5]). While relatively infrequent in adults, even those who are 
HIV-infected, meningitis due to Salmonella species is associated with 
a high mortality rate.[1]
Case presentation
A 33-year-old woman had tested HIV-positive in 2011; her 
baseline CD4 count was unknown. She had received antiretroviral 
therapy (ART) since 2011 (initial regimen unknown, changed to 
a fixed-dose combination drug in August 2013). At that time her 
CD4 count was 67 cells/µL. She had had pulmonary tuberculosis 
in 2012 and had completed 6 months of antituberculosis 
treatment. At the time of her admission in July 2014, her CD4 
count was 96 cells/µL and her HIV viral load was suppressed. 
She reported having had a generalised headache for 5 days, and 
had a longstanding history of visual impairment. Her vision 
had deteriorated acutely 2 days before admission. There was no 
associated vomiting, fever, photophobia, confusion or seizures. 
She had a recent history of constipation but no diarrhoea or 
abdominal discomfort.
Clinically, the patient was chronically ill with generalised wasting. 
Recorded vital signs on admission were essentially normal apart 
from sinus tachycardia. She had pallor, clubbing and significant 
lymphadenopathy, but no oral candidiasis.
Central nervous system assessment revealed that the patient was 
conscious, alert and fully orientated. She had terminal nuchal rigidity. 
She was blind and had no perception of light; fundal examination 
showed pallor of both optic discs, the left being more affected than 
the right. There were no gross motor or sensory deficits, but her gait 
was not assessed owing to her visual deficit. Findings on examination 
of the other systems were unremarkable.
The working diagnosis was acute meningitis, and intravenous (IV) 
ceftriaxone 2 g 12-hourly was empirically commenced, pending 
results of a lumbar puncture (LP).
Blood investigations were undertaken. An enhanced computed 
tomography (CT) scan of the brain showed no intracranial 
abnormality. As there were no contraindications, a diagnostic LP 
was performed. Blood cultures and stool microscopy studies were 
negative, as was syphilis serology. An ophthalmological assessment 
led to the conclusion that the blindness was due to bilateral disc 
atrophy secondary to meningitis.
Cerebrospinal fluid (CSF) findings on admission and after 12 days 
of antibiotic treatment are shown in Table 1.
The patient completed 2 weeks of IV ceftriaxone. In view of the 
CSF findings following ceftriaxone therapy, she was commenced on 
antituberculosis therapy with steroids.
The salmonellae
Salmonellae are Gram-negative, facultative anaerobic bacilli that can 
colonise a wide range of mammalian hosts. Two distinct species exist, 
S. enterica and S. bongori. Most of the isolates that are patho genic in 
humans belong to S. enterica, comprising more than 2 600 different 
serovars differentiated by their antigenic presentation.[6]
S. enterica are food-borne pathogens capable of causing both 
intestinal and extraintestinal infections in humans. The innate 
virulence of each serovar and host resistance are key determinants 
of clinical manifestations.[7] Human infections are classically divided 
into diseases caused by typhoidal salmonellae or NTS. The typhoidal 
serotypes (S. typhi and S. paratyphi) are restricted to human hosts 
and are highly invasive, but are rarely associated with immuno-
suppression. In contrast, NTS have a more severe and invasive 
presentation in immunocompromised adults.[1,7]
Burden of disease and epidemiology
The burden of NTS is significant, with an estimated 93.8 million cases 
and 155 000 deaths globally each year.[6] Despite global morbidity, 
mortality is primarily restricted to the developing world. In sub-
Saharan Africa, invasive NTS is a major cause of bacteraemia in 
adults and children,[7] with an estimated annual incidence of 175 - 
388/100 000 children aged 3 - 5 years and 1 800 - 9 000/100 000 
HIV-infected adults.[7,8] Case fatality and relapse rates are high,[7] 
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antibiotic resistance is an increasing problem,[9] and no vaccine is 
currently available.[6] Despite evidence that the initiation of ART in 
HIV-infected adults leads to a reduction in recurrent invasive NTS 
disease, there are no population data to demonstrate the impact of 
ART on the incidence of NTS disease.[7]
The incidence of NTS is highest during and after the rainy season 
in tropical climates and during the warmer months in temperate 
climates.[8]
Certain NTS serovars cause extraintestinal infections, the serotypes 
varying in different countries. The most common serotypes across 
Africa are S. typhimurium and S. entiritidis, although investigators at 
some sites report contributions from other serotypes such as S. isangi 
in South Africa, S. concord in Ethiopia and S. stanleyville and S. dublin 
in Mali.[8] Studies conducted in Malawi and Kenya have isolated a 
novel variant of S. typhimurium (ST 313), which has frequently been 
implicated in cases of invasive NTS in the sub-Saharan region.[9]
Pathogenesis
Salmonellae are typically acquired from the environment by oral 
ingestion of contaminated water or food, or through contact with 
a carrier. Following ingestion, the bacteria bypass gastric defences, 
multiply, and penetrate the intestinal mucosa. They survive within 
the macrophages of the reticuloendothelial system and disseminate 
via the systemic circulation, thereby causing infection.[10] Cell-
mediated immunity is vital for defence against intracellular bacteria 
such as salmonellae, and leucocytes, especially lymphocytes, are 
essential to host defence.[1] The ability of salmonellae to persist 
depends on a balance between immune responses that lead to the 
clearance of the pathogen and avoidance of damage to host tissues. [10] 
In their study evaluating the long-term relationship of Salmonella 
with its host, Ruby et al.[10] showed that the balance of T-helper cells 
subsets 1 and 2 (Th1/Th2) is crucial for the maintenance of bacterial 
persistence and survival of the host, as a strong Th1 response leads 
to clearance of the bacteria, while Th2 skewing leads to susceptibility 
and death of the host.[10]
Three essential immunological defects can probably explain the 
invasive pathogenesis[8] and high rate of recurrence of NTS in HIV-
infected adults.[7] The first involves the gastrointestinal mucosa, which 
is one of the earliest and most affected sites of CD4 T-cell depletion, 
especially of interleukin-17-producing T cells (Th17 cells), in HIV 
infection.[7,8] Th17 cells and their associated family of cytokines are 
essential for the integrity, repair and maintenance of the epithelial 
mucosal barrier and enable epithelial cell expression of antimicrobial 
peptides,[8] thereby playing a vital role in controlling local invasion 
by Salmonella. Moreover, Th17 cells have an important role in the 
stimulation of innate immune responses, by mediating neutrophil 
chemoattraction and function. Secondly, cytokine responses are 
crucial for control of intracellular Salmonella infection. However, 
in advanced HIV there is dysregulated cytokine production during 
intracellular infection, which appears to allow persistence and 
recurrence of invasive NTS.[1] Thirdly, the significance of antibodies 
is increasingly recognised, both for serum killing and intracellular 
oxidative killing of invasive Salmonella. Antibodies directed against 
Salmonella lipopolysaccharide are shown to impair serum killing 
by blocking or competing with coexisting effective bactericidal 
antibodies directed against outer membrane proteins of Salmonella.[7]
Clinical presentation
Clinical manifestations range from subclinical infection to severe 
life-threatening disease, viz. enteric (68%), Salmonella sepsis (8%), 
non-enteric focal infections (7%, including meningitis (0.8%)), and a 
chronic carrier state (15%).[5]
NTS infections present primarily with a self-limiting enterocolitis, 
which often does not require antimicrobial therapy; invasive NTS 
infections manifest with high fever, hepatosplenomegaly and respira-
tory complications, with intestinal symptoms often being absent.[8] 
When Salmonella bacteria enter the systemic circulation, all tissues 
and organs are susceptible, leading to focal Salmonella infections, 
including meningitis.[4] It is postulated that high-grade bacteraemia 
is required for meningeal invasion, although in the case of NTS this 
bacteraemia may not be detected in up to 40% of cases.[3] Clinical 
manifestations of NTS meningitis appear to be typical for bacterial 
meningitis. The mortality rate associated with NTS focal infections 
is high, in the order of 30% in published series, particularly in 
the case of meningitis, when it approaches 50%.[3] Impairment of 
consciousness at presentation has been cited as a risk factor for 
mortality in such cases,[3] and of patients who do survive, 43% are 
left with permanent neurological deficits.[4] Ventriculitis, subdural 
empyema, hydrocephalus and rarely brain abscess are recognised 
acute neurological complications of Salmonella meningitis.[4]
Chronically infected hosts are often asymptomatic and transmit 
disease to naive hosts via faecal shedding of bacteria, thereby serving 
as a critical reservoir for disease.[10] However, despite symptoms lasting 
only for a few days, adults may excrete Salmonella for an average of a 
month following infection, while children under the age of 5 years shed 
bacteria in their faeces for an average of 7 weeks.[11] Several studies have 
shown that treatment with antibiotics can prolong shedding of NTS 
bacteria,[11] although these findings are controversial.[6]
Our patient had no history suggestive of a preceding bout of 
enterocolitis, yet she had clinical features in keeping with meningitis. 
It is likely that she had significant bacteraemia (on account of the 
organism being isolated from the CSF), but was one of the 40% of 
Table 1. CSF findings on admission and after 12 days of 
antibiotic treatment
On admission
Protein 2.99 g/L
Glucose <0.3 mmol/L
Chloride 115 mmol/L
Polymorphonuclear cells 970/µL
Lymphocytes 0/µL
Erythrocytes 60/µL
Gram stain Gram-negative bacilli
Culture Salmonella spp.
Sensitivity Most antibiotics, 
including ceftriaxone
 Cryptococcal latex antigen test Negative
Gene Xpert Negative
Following 12 days of IV antibiotics
Protein 4.11 g/L
Glucose 2.2 mmol/L
Chloride 106 mmol/L
Polymorphonuclear cells 6/µL
Lymphocytes 106/µL
Erythrocytes 510/µL (traumatic tap) 
Gram stain No bacteria
Culture No growth
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reported cases in whom this may not be detected. Stool microscopy 
studies were also negative, which eliminated her as a carrier.
Investigations
The diagnosis of NTS infection is based on isolation of the organism 
from freshly passed stool, or from blood or any other normally sterile 
body fluid. All salmonellae isolated in clinical laboratories should be 
sent to local public health departments for serotyping.[3]
Once a working diagnosis of meningitis is made, an LP is the 
key investigation to confirm the clinical suspicion. It is vital to bear 
in mind the contraindications to such a procedure, especially in 
resource-limited settings where there may not be ready access to a 
CT scan facility. According to recently published guidelines for the 
management of acute meningitis,[12] isolated cranial nerve palsies are 
not a contraindication to LP, but there is need for vigilance when the 
patient has a concomitant depressed level of consciousness.
The CSF is usually normal or reveals mild pleocytosis, elevated 
protein and a decreased glucose level.[3] The serotypes isolated from 
CSF are similar to those causing bacteraemia, and it is has therefore 
been postulated that no serotype has a particular predilection for the 
central nervous system.[13]
Treatment
Uncomplicated NTS gastroenteritis should be managed sympto-
matically, as the symptoms are usually self-limited and the duration 
of fever and diarrhoea is not significantly decreased by antibiotic 
therapy; however, antimicrobials may be considered in patients at 
increased risk of invasive NTS infections.[11]
There are no studies indicating the best combined antimicrobial 
and ART regimen to treat acute infection and prevent relapse.[8] The 
Infectious Disease Society of America guidelines[8] for the manage-
ment of invasive NTS in HIV-infected adults recommend 2 - 6 
weeks of fluoroquinolone therapy.[8] Feasey et al.[8] propose that rapid 
initiation of ART may prevent relapse. Moreover, zidovudine has been 
documented to show anti-Salmonella activity in vitro and appears to 
be clinically useful in the prevention of relapse of infection.[11]
In Africa and most other developing regions, multidrug resistance 
is an escalating problem and is linked to poor disease outcome.[6] 
Currently the fluoroquinolones are the first-line agents for salmon-
ellosis, given their efficacy against intracellular Gram-negative 
bacteria,[7] with third-generation cephalosporins reserved as second-
line agents. Azithromycin (a macrolide) has shown activity against 
both nalidixic acid-resistant and multidrug-resistant strains.[6]
Treatment of Salmonella meningitis is very difficult, and 
has never been standardised; however, it is recommended 
that antimicrobial therapy be used for 4 weeks.[13] Prolonged 
therapy for Salmonella meningitis is indicated in view of slow 
response and the high probability of relapse (~64%).[4] Various 
alternative drugs have been used during recent decades, including 
chloramphenicol, ampicillin, co-trimoxazole, third-generation 
cephalosporins and fluoroquinolones, with the former three 
producing unsatisfactory results.[13] For meningitis or deep CNS 
involvement, high-dose ceftriaxone is the best choice for optimal 
penetration of the blood-brain barrier.[11] There are currently no 
data to suggest that combination therapy (e.g. a ﬂuoroquinolone 
with a third-generation cephalosporin) is more effective than 
either as a single agent.[11,13]
Our patient’s treatment regimen unfortunately spanned a period 
of only 2 weeks, as the finding of sterile CSF following only 12 
days of IV ceftriaxone led us to be satisfied with progress and 
therefore to conclude prematurely that she had been adequately 
treated. According to suggested guidelines, therapy should have been 
prolonged for a further 2 weeks. Of note, she had been on ART since 
2011 and her HIV viral load was supressed, yet she still acquired an 
opportunistic NTS infection reflecting her immunosupression (and 
low CD4 count of only 96 cells/µL).
Our decision to commence antituberculosis therapy was prompted 
by the last LP findings (high CSF protein, low CSF glucose, and a 
predominant lymphocytosis), her immunocompromised state and 
chronic tuberculous meningitis being the most likely explanation for 
her loss of vision.
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